Citation Impact
Citing Papers
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
2016 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Role of the gut microbiota in immunity and inflammatory disease
2013 Standout
Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials
2013
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
2012
Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment
2016
Update on pulmonary disease due to non-tuberculous mycobacteria
2016
Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota
2013
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
2010
Nontuberculous Pulmonary Mycobacteriosis in Denmark
2009
Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London
2012
Mortality after Respiratory Isolation of Nontuberculous Mycobacteria: A Comparison of Patients Who Did and Did Not Meet Disease Criteria
2017
Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
2011
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Health‐related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review
2016
Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients
2019
Works of C. Andréjak being referenced
Non-tuberculous mycobacteria pulmonary infection: Management and follow-up of 31 infected patients
2007
Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study
2016
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
2008
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy
2012
Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations
2015